| Literature DB >> 32161689 |
Jialiang Hui1, Ruiyu Liu1, Haibo Zhang1, Shuhua He1, Anyang Wei1.
Abstract
PURPOSE: Erectile dysfunction (ED) is one of the most common male-disease globally. Despite efforts to explain its pathogenesis, the molecular mechanisms of ED are still not well understood.Entities:
Keywords: Bioinformatics; Biomarkers; ED; Erectile dysfunction
Year: 2020 PMID: 32161689 PMCID: PMC7050549 DOI: 10.7717/peerj.8653
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1DEGs in ED and GO & KEGG pathway enrichment analysis of DEGs.
(A) DEGs were selected with a fold change >1 and P-value < 0.01 among the mRNA expression profiling set GSE10804. (B) Biological processes (BP) of DEGs. (C) Molecular function (MF) of DEGs. (D) Cell component (CC) of DEGs. (E) KEGG pathway of DEGs.
GO and KEGG pathway enhancement analysis of upregulated DEGs in ED samples.
| GO:0007214 | Gamma-aminobutyric acid signaling pathway | 3 | 1.923 | 0.006 |
| GO:0030316 | Osteoclast differentiation | 3 | 1.923 | 0.009 |
| ptr04924 | Renin secretion | 5 | 3.205 | 0.004 |
Notes.
Gene Ontology
Kyoto Encyclopedia of Genes and Genomes
differentially expressed genes
erectile dysfunction
GO and KEGG pathway enrichment analysis of downregulated DEGs in ED samples.
| GO:0030198 | Extracellular matrix organization | 22 | 6.452 | 1.28E−10 |
| GO:0007155 | Cell adhesion | 30 | 8.798 | 1.20E−08 |
| GO:0030574 | Collagen catabolic process | 12 | 3.519 | 2.61E−08 |
| GO:0060021 | Palate development | 12 | 3.519 | 1.65E−07 |
| GO:0001501 | Skeletal system development | 15 | 4.399 | 2.98E−07 |
| GO:0030199 | Collagen fibril organization | 9 | 2.639 | 5.20E−07 |
| GO:0007267 | Cell–cell signaling | 18 | 5.279 | 6.48E−06 |
| GO:0060326 | Cell chemotaxis | 9 | 2.639 | 2.80E−05 |
| GO:0046488 | Phosphatidylinositol metabolic process | 5 | 1.466 | 3.61E−05 |
| GO:0030335 | Positive regulation of cell migration | 13 | 3.812 | 1.90E−04 |
| GO:0005201 | Extracellular matrix structural constituent | 13 | 3.812 | 2.69E−09 |
| GO:0048407 | Platelet-derived growth factor binding | 7 | 2.053 | 1.50E−08 |
| GO:0005509 | Calcium ion binding | 29 | 8.504 | 1.32E−04 |
| GO:0008201 | Heparin binding | 12 | 3.519 | 1.74E−04 |
| GO:0008092 | Cytoskeletal protein binding | 7 | 2.053 | 2.26E−04 |
| GO:0005178 | Integrin binding | 9 | 2.639 | 6.76E−04 |
| GO:0003779 | Actin binding | 14 | 4.106 | 1.85E−03 |
| GO:0008009 | Chemokine activity | 6 | 1.76 | 1.94E−03 |
| GO:0008083 | Growth factor activity | 10 | 2.933 | 2.95E−03 |
| GO:0005518 | Collagen binding | 6 | 1.76 | 4.71E−03 |
| GO:0005615 | Extracellular space | 64 | 18.768 | 1.48E−12 |
| GO:0005576 | Extracellular region | 68 | 19.941 | 4.84E−11 |
| GO:0031012 | Extracellular matrix | 26 | 7.625 | 1.53E−10 |
| GO:0005578 | Proteinaceous extracellular matrix | 21 | 6.158 | 8.74E−08 |
| GO:0009986 | Cell surface | 30 | 8.798 | 1.74E−07 |
| GO:0070062 | Extracellular exosome | 87 | 25.513 | 2.27E−07 |
| GO:0005788 | Endoplasmic reticulum lumen | 15 | 4.399 | 1.01E−05 |
| GO:0005604 | Basement membrane | 10 | 2.933 | 1.18E−05 |
| GO:0005886 | Plasma membrane | 107 | 31.378 | 2.58E−05 |
| GO:0009897 | External side of plasma membrane | 15 | 4.399 | 3.23E−05 |
| hsa04512 | ECM-receptor interaction | 13 | 3.812 | 3.56E−07 |
| hsa04151 | PI3K-Akt signaling pathway | 24 | 7.038 | 1.53E−06 |
| hsa04510 | Focal adhesion | 18 | 5.279 | 2.36E−06 |
| hsa04974 | Protein digestion and absorption | 12 | 3.519 | 3.03E−06 |
| hsa05200 | Pathways in cancer | 23 | 6.745 | 4.27E−05 |
| hsa05146 | Amoebiasis | 11 | 3.226 | 1.03E−04 |
| hsa05205 | Proteoglycans in cancer | 14 | 4.106 | 4.32E−04 |
| hsa04540 | Gap junction | 9 | 2.639 | 6.61E−04 |
| hsa04670 | Leukocyte transendothelial migration | 10 | 2.933 | 1.10E−03 |
| hsa04730 | Long-term depression | 7 | 2.053 | 1.93E−03 |
Notes.
Gene Ontology
Kyoto Encyclopedia of Genes and Genomes
differentially expressed genes
erectile dysfunction
Figure 2PPI network and the most significant module of DEGs.
(A) The PPI network of DEGs was created using Cytoscape. (B) The most critical module was obtained from the PPI network with 25 nodes and 145 edges. (C) The biological process analysis of hub genes was constructed using BiNGO. P < 0.01 was considered statistically significant. (D) The biological process analysis of hub genes was created using STRING.
GO and KEGG pathway enrichment analysis of hub DEGs in ED samples.
| GO:0071230 | Cellular response to amino acid stimulus | 5 | 20 | 2.53E−07 |
| GO:0006954 | Inflammatory response | 7 | 28 | 4.93E−07 |
| GO:0030199 | Collagen fibril organization | 4 | 16 | 1.06E−05 |
| GO:0070208 | Protein heterotrimerization | 3 | 12 | 4.91E−05 |
| GO:0006955 | Immune response | 5 | 20 | 1.44E−04 |
| GO:0005201 | Extracellular matrix structural constituent | 8 | 32 | 4.34E−14 |
| GO:0008009 | Chemokine activity | 3 | 12 | 1.84E−03 |
| GO:0005581 | Collagen trimer | 7 | 28 | 3.48E−11 |
| GO:0005578 | Proteinaceous extracellular matrix | 8 | 32 | 1.54E−09 |
| GO:0005615 | Extracellular space | 9 | 36 | 2.31E−05 |
| GO:0005587 | Collagen type IV trimer | 3 | 12 | 3.31E−05 |
| GO:0005584 | Collagen type I trimer | 2 | 8 | 3.04E−03 |
| ptr04974 | Protein digestion and absorption | 11 | 44 | 2.40E−14 |
| ptr04512 | ECM-receptor interaction | 10 | 40 | 2.56E−12 |
| ptr04151 | PI3K-Akt signaling pathway | 12 | 48 | 1.40E−09 |
| ptr04510 | Focal adhesion | 10 | 40 | 5.78E−09 |
| ptr05146 | Amoebiasis | 8 | 32 | 2.31E−08 |
Notes.
Gene Ontology
Kyoto Encyclopedia of Genes and Genomes
differentially expressed genes
erectile dysfunction
Functional roles of 25 hub genes with degree ≥10.
| C3 | Complement component 3 | 3.36E−03 | 1.324 |
| CCR5 | C-C motif chemokine receptor 5 | 6.96E−03 | −1.395 |
| COL1A1 | Collagen type I alpha 1 chain | 1.78E−09 | −10.353 |
| COL1A2 | Collagen type I alpha 2 chain | 1.36E−06 | −4.873 |
| COL21A1 | Collagen type XXI alpha 1 chain | 9.97E−03 | −1.804 |
| COL2A1 | Collagen type II alpha 1 chain | 4.85E−05 | −1.92 |
| COL3A1 | Collagen type III alpha 1 chain | 1.16E−04 | −2.991 |
| COL4A1 | Collagen type IV alpha 1 chain | 6.43E−03 | −1.865 |
| COL4A2 | Collagen type IV alpha 2 chain | 1.85E−03 | −1.871 |
| COL4A4 | Collagen type IV alpha 4 chain | 5.07E−03 | −1.064 |
| COL5A3 | Collagen type V alpha 3 chain | 9.11E−03 | −2.508 |
| COL6A1 | Collagen type VI alpha 1 chain | 4.87E−05 | −4.282 |
| COL6A2 | Collagen type VI alpha 2 chain | 1.65E−05 | −5.482 |
| COL6A3 | Collagen type VI alpha 3 chain | 7.16E−07 | −7.906 |
| CXCL11 | C-X-C motif chemokine ligand 11 | 2.30E−03 | −1.368 |
| CXCL12 | C-X-C motif chemokine ligand 12 | 4.03E−03 | −2.309 |
| CXCL5 | C-X-C motif chemokine ligand 5 | 1.29E−03 | −2.202 |
| CXCL6 | C-X-C motif chemokine ligand 6 | 4.23E−03 | −1.948 |
| DRD2 | Dopamine receptor D2 | 1.71E−03 | −1.038 |
| FPR2 | Formyl peptide receptor 2 | 9.28E−04 | 1.731 |
| GABBR2 | Gamma-aminobutyric acid type B receptor subunit 2 | 3.17E−06 | 2.374 |
| GNAI1 | G protein subunit alpha i1 | 1.73E−04 | −1.107 |
| GNG7 | G protein subunit gamma 7 | 4.59E−03 | −1.475 |
| LEPREL1 | P3H2 (LEPREL1) prolyl 3-hydroxylase 2 | – | – |
| LPAR1 | Lysophosphatidic acid receptor 1 | 2.28E−03 | −2.632 |
Figure 3KEGG pathway enrichment analysis of hub DEGs.
(A) Protein digestion and absorption. (B) ECM-receptor interaction. (C) PI3K-Akt signaling pathway.